Genetic drivers of progression in Alzheimer's disease are distinct from disease risk
Celeste E Cohen, Shane Fernandez, Umran Yaman, Ahmad R Ehyaei, Tenielle Porter, Eleanor O'Brien, Australian Imaging Biomarkers and Lifestyle Study, Alzheimer’s Disease Neuroimaging Initiative et al.. medRxiv : the preprint server for health sciences, 2025-11-19
Topic: Genetics and APOE
Plain-language summary
Established AD risk factors, including APOE ε4 dosage and polygenic risk scores, were not associated with disease progression amyloid positive individuals who are actively declining. A mixed effects GWAS meta-analysis revealed one genome-wide significant locus on chromosome 22 (rs78369883) and 25 nominally significant loci linked with AD progression. Functional annotation, finemapping, and colocalization analyses implicated genes primarily involved in immune response, neurodegeneration (including tau pathology), brain resilience, and neurogenesis. These progression-related genes were significantly enriched in neuronal-interferon-microglial signalling pathways and normal homeostatic processes of neuronal networks, with specific enrichment in dopaminergic and inhibitory neuronal populations. These findings enhance our understanding of the biological underpinnings of AD progression, opening new avenues for therapeutic intervention.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cohen, C. E., Fernandez, S., Yaman, U., Ehyaei, A. R., Porter, T., O'Brien, E., et al. (2025). Genetic drivers of progression in Alzheimer's disease are distinct from disease risk. medRxiv : the preprint server for health sciences. https://doi.org/10.1101/2025.11.17.25340247
Vancouver
Cohen CE, Fernandez S, Yaman U, Ehyaei AR, Porter T, O'Brien E, et al. Genetic drivers of progression in Alzheimer's disease are distinct from disease risk. medRxiv : the preprint server for health sciences. 2025. doi:10.1101/2025.11.17.25340247. PMID: 41332834.
BibTeX
@article{cohen2025-41332834,
author = {Cohen, Celeste E and Fernandez, Shane and Yaman, Umran and Ehyaei, Ahmad R and Porter, Tenielle and O'Brien, Eleanor and {Australian Imaging Biomarkers and Lifestyle Study} and {Alzheimer’s Disease Neuroimaging Initiative} and others},
title = {{Genetic drivers of progression in Alzheimer's disease are distinct from disease risk}},
journal = {medRxiv : the preprint server for health sciences},
year = {2025},
doi = {10.1101/2025.11.17.25340247},
pmid = {41332834},
url = {https://doi.org/10.1101/2025.11.17.25340247}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Established AD risk factors, including APOE ε4 dosage and polygenic risk scores, were not associated with disease progression amyloid positive individuals who are actively declining.
- A mixed effects GWAS meta-analysis revealed one genome-wide significant locus on chromosome 22 (rs78369883) and 25 nominally significant loci linked with AD progression.
- Functional annotation, finemapping, and colocalization analyses implicated genes primarily involved in immune response, neurodegeneration (including tau pathology), brain resilience, and neurogenesis.
- These progression-related genes were significantly enriched in neuronal-interferon-microglial signalling pathways and normal homeostatic processes of neuronal networks, with specific enrichment in dopaminergic and inhibitory neuronal populations.
- These findings enhance our understanding of the biological underpinnings of AD progression, opening new avenues for therapeutic intervention.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designmeta-analysis
- Participants222
- Evidence strengthHigh
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 57 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 34 of the 60 points we could judge it on, which is 57 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (medRxiv : the preprint server for health sciences) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 222 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41332834) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 34 / 60 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 34 of the 60 points we could judge it on is 57 out of 100. |
| Total | 57 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “genetics”
346 studies in the library carry the topic tag “genetics”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 346 tagged studies.